Selection and use of lactic acid bacteria preventing bone loss in mammals
AssigneesBoard of Trustees of Michigan State University, Biogaia AB
InventorsEamonn Connolly, Robert Allen Britton, Laura Rae McCabe
Life of this patent
Estimating the term…
Abstract
The present invention comprises a method for selecting lactic acid bacterial strains effective for preventing bone loss in humans and strains that have been selected according to the presented method. The selection method is based on the strains capability of reestablishing an altered microbial community to normal and/or harboring at least one of four specific SNPs.
Claims2
A method for preventing or treating bone loss, comprising administering to an individual in need thereof a lactic acid bacterial strain comprising a nucleic acid sequence having at least 99% identity to the nucleic acid sequence of the genome of L. reuteri JCM 1112 (SEQ ID NO:1), and wherein the lactic acid bacterial strain harbors a nucleotide relative to the genome of Lactobacillus reuteri JCM 1112 (SEQ ID NO:
- 1) in all of the following four positions:
- C in base pair 271 391, G in base pair 453 538, G in base pair 529 228, and C in base pair 599 338.
Dependencies are inferred from the claim text.